Cargando…
Inducible apelin receptor knockdown reduces differentiation efficiency and contractility of hESC-derived cardiomyocytes
AIMS: The apelin receptor, a G protein-coupled receptor, has emerged as a key regulator of cardiovascular development, physiology, and disease. However, there is a lack of suitable human in vitro models to investigate the apelinergic system in cardiovascular cell types. For the first time we have us...
Autores principales: | Macrae, Robyn G C, Colzani, Maria T, Williams, Thomas L, Bayraktar, Semih, Kuc, Rhoda E, Pullinger, Anna L, Bernard, William G, Robinson, Emma L, Davenport, Emma E, Maguire, Janet J, Sinha, Sanjay, Davenport, Anthony P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064845/ https://www.ncbi.nlm.nih.gov/pubmed/36239923 http://dx.doi.org/10.1093/cvr/cvac065 |
Ejemplares similares
-
Modulating hESC-derived cardiomyocyte and endothelial cell function with triple-helical peptides for heart tissue engineering
por: Colzani, Maria, et al.
Publicado: (2021) -
Expanding the apelin receptor pharmacological toolbox using novel fluorescent ligands
por: Williams, Thomas L., et al.
Publicado: (2023) -
c-JUN is a barrier in hESC to cardiomyocyte transition
por: Zhong, Hui, et al.
Publicado: (2023) -
Apelin-36-[L28A] and Apelin-36-[L28C(30kDa-PEG)] peptides that improve diet induced obesity are G protein biased ligands at the apelin receptor
por: Nyimanu, Duuamene, et al.
Publicado: (2019) -
Human embryonic stem cell-derived cardiomyocyte platform screens inhibitors of SARS-CoV-2 infection
por: Williams, Thomas L., et al.
Publicado: (2021)